Literature DB >> 8842035

Characterization and stability of N-terminally PEGylated rhG-CSF.

O B Kinstler1, D N Brems, S L Lauren, A G Paige, J B Hamburger, M J Treuheit.   

Abstract

PURPOSE: The liquid stability of rhG-CSF was investigated after polyethylene glycol (PEG) with an average molecular weight of 6000 daltons was covalently attached to the N-terminal methionine residue.
METHODS: The conjugation methods chosen for modifying the N-terminal residue were alkylation and acylation. The N-terminally PEGylated rhG-CSF conjugates were purified by cation exchange chromatography. The physical characterization methods of SDS-PAGE, endoproteinase peptide mapping, circular dichroism and in-vivo bioassay were used to test for differences between the PEG-rhG-CSF molecules.
RESULTS: Physical characterization indicated no apparent differences in the rhG-CSF molecules that were conjugated with either method. Stability, in liquid at elevated temperatures, of these conjugated molecules indicated that the primary pathway of degradation was aggregation. Conjugation through alkylation offered the distinct advantage of decreasing, by approximately 5 times, the amount of aggregation present as compared to acylation.
CONCLUSIONS: We suggest, that the increased stability observed for the molecules utilizing the alkylation conjugation method may be due to the preservation of charge on the alpha amino group of rhG-CSF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842035     DOI: 10.1023/a:1016042220817

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells.

Authors:  L M Souza; T C Boone; J Gabrilove; P H Lai; K M Zsebo; D C Murdock; V R Chazin; J Bruszewski; H Lu; K K Chen; J Barendt; E Platzer; M A S Moore; R Mertelsmann; K Welte
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor.

Authors:  A M Cohen; K M Zsebo; H Inoue; D Hines; T C Boone; V R Chazin; L Tsai; T Ritch; L M Souza
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

4.  Site-specific attachment of functionalized poly(ethylene glycol) to the amino terminus of proteins.

Authors:  H F Gaertner; R E Offord
Journal:  Bioconjug Chem       Date:  1996 Jan-Feb       Impact factor: 4.774

5.  Relationship of effective molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified with water-soluble polymers.

Authors:  M J Knauf; D P Bell; P Hirtzer; Z P Luo; J D Young; N V Katre
Journal:  J Biol Chem       Date:  1988-10-15       Impact factor: 5.157

Review 6.  The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors.

Authors:  D Metcalf
Journal:  Blood       Date:  1986-02       Impact factor: 22.113

7.  Reduction and fluorescent labeling of cyst(e)ine-containing proteins for subsequent structural analyses.

Authors:  T L Kirley
Journal:  Anal Biochem       Date:  1989-08-01       Impact factor: 3.365

8.  Alteration of the circulating life and antigenic properties of bovine adenosine deaminase in mice by attachment of polyethylene glycol.

Authors:  S Davis; A Abuchowski; Y K Park; F F Davis
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

9.  Chemical modification of recombinant human granulocyte colony-stimulating factor by polyethylene glycol increases its biological activity in vivo.

Authors:  R Satake-Ishikawa; M Ishikawa; Y Okada; M Kakitani; M Kawagishi; S Matsuki; K Asano
Journal:  Cell Struct Funct       Date:  1992-06       Impact factor: 2.212

Review 10.  Biomedical and biotechnological applications of PEG- and PM-modified proteins.

Authors:  Y Inada; M Furukawa; H Sasaki; Y Kodera; M Hiroto; H Nishimura; A Matsushima
Journal:  Trends Biotechnol       Date:  1995-03       Impact factor: 19.536

View more
  36 in total

1.  NB1-C16-insulin: site-specific synthesis, purification, and biological activity.

Authors:  H Mei; C Yu; K K Chan
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

2.  N-PEGylation of a reverse turn is stabilizing in multiple sequence contexts, unlike N-GlcNAcylation.

Authors:  Joshua L Price; Evan T Powers; Jeffery W Kelly
Journal:  ACS Chem Biol       Date:  2011-09-22       Impact factor: 5.100

3.  Sodium chloride enhances the storage and conformational stability of BDNF and PEG-BDNF.

Authors:  W J Callahan; L O Narhi; A A Kosky; M J Treuheit
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

4.  The Surface of Protein λ6-85 Can Act as a Template for Recurring Poly(ethylene glycol) Structure.

Authors:  Shu-Han Chao; Jan Schäfer; Martin Gruebele
Journal:  Biochemistry       Date:  2017-10-06       Impact factor: 3.162

5.  Trehalose Glycopolymer Enhances Both Solution Stability and Pharmacokinetics of a Therapeutic Protein.

Authors:  Yang Liu; Juneyoung Lee; Kathryn M Mansfield; Jeong Hoon Ko; Sahar Sallam; Chrys Wesdemiotis; Heather D Maynard
Journal:  Bioconjug Chem       Date:  2017-01-03       Impact factor: 4.774

6.  Site-Specific Protein PEGylation: Application to Cysteine Analogs of Recombinant Human Granulocyte Colony-Stimulating Factor.

Authors:  Mary S Rosendahl; Daniel H Doherty; Darin J Smith; Alison M Bendele; George N Cox
Journal:  Bioprocess Int       Date:  2005-04

7.  Isolation, characterization, and stability of positional isomers of mono-PEGylated salmon calcitonins.

Authors:  K C Lee; S C Moon; M O Park; J T Lee; D H Na; S D Yoo; H S Lee; P P DeLuca
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

8.  PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative.

Authors:  Jose Ramon; Vivian Saez; Reynier Baez; Raymersy Aldana; Eugenio Hardy
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

9.  PEGylation of brain-derived neurotrophic factor for preserved biological activity and enhanced spinal cord distribution.

Authors:  Ryan G Soderquist; Erin D Milligan; Evan M Sloane; Jacqueline A Harrison; Klarika K Douvas; Joseph M Potter; Travis S Hughes; Raymond A Chavez; Kirk Johnson; Linda R Watkins; Melissa J Mahoney
Journal:  J Biomed Mater Res A       Date:  2009-12       Impact factor: 4.396

10.  Preparation and stability of poly(ethylene glycol) (PEG)ylated octreotide for application to microsphere delivery.

Authors:  Dong Hee Na; Santos B Murty; Kang Choon Lee; B C Thanoo; Patrick P DeLuca
Journal:  AAPS PharmSciTech       Date:  2003-12-31       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.